.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Teva
AstraZeneca
Harvard Business School
Fish and Richardson
Johnson and Johnson
McKinsey
Chubb
Daiichi Sankyo
Accenture

Generated: December 14, 2017

DrugPatentWatch Database Preview

ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Rosiglitazone Maleate And Metformin Hydrochloride, and what generic alternatives are available?

Rosiglitazone Maleate And Metformin Hydrochloride is a drug marketed by Teva and is included in one NDA.

The generic ingredient in ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE is metformin hydrochloride; rosiglitazone maleate. There are forty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the metformin hydrochloride; rosiglitazone maleate profile page.

Summary for ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE

Drug patent expirations by year for ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
TevaROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDEmetformin hydrochloride; rosiglitazone maleateTABLET;ORAL077337-004May 7, 2014RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
TevaROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDEmetformin hydrochloride; rosiglitazone maleateTABLET;ORAL077337-005May 19, 2017RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDEmetformin hydrochloride; rosiglitazone maleateTABLET;ORAL077337-003May 7, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDEmetformin hydrochloride; rosiglitazone maleateTABLET;ORAL077337-001May 7, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDEmetformin hydrochloride; rosiglitazone maleateTABLET;ORAL077337-002May 7, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
Baxter
Daiichi Sankyo
Medtronic
McKesson
Harvard Business School
Express Scripts
Chubb
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot